Savant Capital LLC cut its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 95.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 988 shares of the technology company’s stock after selling 23,262 shares during the period. Savant Capital LLC’s holdings in Veeva Systems were worth $221,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Huntington National Bank boosted its holdings in Veeva Systems by 5.3% in the fourth quarter. Huntington National Bank now owns 2,084 shares of the technology company’s stock valued at $465,000 after purchasing an additional 105 shares during the period. Geode Capital Management LLC boosted its holdings in Veeva Systems by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 3,172,716 shares of the technology company’s stock valued at $706,442,000 after purchasing an additional 23,117 shares during the period. Integrity Alliance LLC. purchased a new position in Veeva Systems in the fourth quarter valued at $886,000. Kestra Investment Management LLC lifted its holdings in Veeva Systems by 2.8% during the 4th quarter. Kestra Investment Management LLC now owns 4,357 shares of the technology company’s stock worth $973,000 after buying an additional 118 shares during the last quarter. Finally, Allstate Corp lifted its holdings in Veeva Systems by 101.8% during the 4th quarter. Allstate Corp now owns 11,827 shares of the technology company’s stock worth $2,640,000 after buying an additional 5,965 shares during the last quarter. 88.20% of the stock is currently owned by hedge funds and other institutional investors.
Key Headlines Impacting Veeva Systems
Here are the key news stories impacting Veeva Systems this week:
- Positive Sentiment: Veeva beat Q1 earnings and revenue estimates, with EPS of $2.24 and revenue of $882.9 million, while also raising its fiscal 2027 outlook. Veeva Systems beats estimates on AI progress
- Positive Sentiment: Management highlighted AI momentum, including Falcon AI agents, CRM migration wins, and the Ostro acquisition, suggesting new growth drivers beyond the core platform. Veeva Systems Q1 Earnings Call Highlights AI Push & Higher Outlook
- Positive Sentiment: Several brokers remained constructive, including Barclays, Oppenheimer, RBC, Needham, BTIG, and Robert W. Baird, many of which kept buy/outperform ratings and elevated price targets. Veeva Systems (VEEV) Receives a Buy from Barclays
- Neutral Sentiment: Citigroup raised its target to $190 and maintained a neutral stance, while UBS and Canaccord also trimmed targets but stayed at neutral/hold, reflecting a more mixed Street view. Analyst updates
- Negative Sentiment: Despite the beat-and-raise quarter, the stock sold off as investors likely questioned how much of the AI optimism is already priced in and whether legacy CRM migration dynamics could pressure growth. Is Veeva Stock Undervalued At $170?
- Negative Sentiment: Goldman Sachs cut its price target to $165 and kept a sell rating, adding to the cautious tone around the name. Veeva Systems price target lowered by Goldman Sachs
Insiders Place Their Bets
Analysts Set New Price Targets
A number of analysts have issued reports on the company. BTIG Research reaffirmed a “buy” rating and set a $340.00 price target on shares of Veeva Systems in a report on Thursday. William Blair reaffirmed an “outperform” rating on shares of Veeva Systems in a report on Tuesday, March 10th. The Goldman Sachs Group decreased their price target on Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a report on Thursday. Wall Street Zen downgraded Veeva Systems from a “buy” rating to a “hold” rating in a report on Sunday, March 22nd. Finally, Citigroup lifted their price target on Veeva Systems from $176.00 to $190.00 and gave the stock a “neutral” rating in a report on Thursday. Eighteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Veeva Systems currently has a consensus rating of “Moderate Buy” and a consensus price target of $250.96.
Read Our Latest Report on VEEV
Veeva Systems Stock Performance
Veeva Systems stock opened at $172.96 on Monday. Veeva Systems Inc. has a fifty-two week low of $148.05 and a fifty-two week high of $310.50. The company has a market capitalization of $28.25 billion, a P/E ratio of 30.83, a PEG ratio of 0.76 and a beta of 0.95. The stock has a 50-day simple moving average of $166.17 and a 200-day simple moving average of $195.17.
Veeva Systems (NYSE:VEEV – Get Free Report) last posted its earnings results on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. Veeva Systems had a return on equity of 13.89% and a net margin of 28.37%.The business had revenue of $882.95 million during the quarter, compared to the consensus estimate of $857.73 million. During the same period in the previous year, the business earned $1.97 EPS. The business’s quarterly revenue was up 16.3% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, analysts forecast that Veeva Systems Inc. will post 6.46 earnings per share for the current year.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
Featured Stories
- Five stocks we like better than Veeva Systems
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
